Restricting Hydrocodone Combination Products Could Limit Patient Access to Painkillers
WASHINGTON, D.C. August 25, 2014 Following is a statement from the American Cancer Society Cancer Action Network (ACS CAN) on the Drug Enforcement Administration 's (DEA) move to restrict access to hydrocodone combination products.